Emergent-Valneva Zika vaccine clears early trial
November 19, 2018 at 17:05 PM EST
A vaccine to prevent infections caused by the deadly mosquito-borne Zika virus induced immune response and was found to be safe in an early stage trial, Emergent BioSolutions Inc and partner Valneva SE said on Monday.